Rancif | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Clinical Trials
- Clinical Trials
Drugs in Dev.
News
Blog
Market Place
Login

Rancif
Canada

PharmaCompass Sponsored Ads

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Contact Supplier

pharmacompass-2-m-2026-04-20

Rancif

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 9 USDMF, 6 CEP/COS, 8 JDMF, 3 EU WC, 5 KDMF, 4 NDC API, 26 Listed Suppliers

43 API Suppliers
9 USDMF
6 CEP/COS
8 JDMF
3 EU WC
5 KDMF
4 NDC API
26 Listed Suppliers

DEVELOPMENTS

81 Drugs in Development

81 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

702 FDF Dossiers, 61 FDA Orange Book, 360 Europe, 3 Canada, 20 Australia, 88 South Africa, 170 Listed Dossiers

702 FDF Dossiers
61 FDA Orange Book
360 Europe
3 Canada
20 Australia
88 South Africa
170 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML), SUSPENSION/DROPS;OTIC - 0.3%;0.1%

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML)
SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 5 SPI Pharma, 10 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 7 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 BioSpectra, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 1 Gloria Interchem, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 1 JJ Chemicals, 22 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 39 Disintegrants & Superdisintegrants, 35 Thickeners and Stabilizers, 35 Granulation, 33 Solubilizers, 33 Direct Compression, 29 Parenteral, 28 Controlled & Modified Release, 23 Topical, 20 Lubricants & Glidants, 19 Film Formers & Plasticizers, 16 Taste Masking, 15 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 8 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

73 Fillers, Diluents & Binders
50 Coating Systems & Additives
39 Disintegrants & Superdisintegrants
35 Thickeners and Stabilizers
35 Granulation
33 Solubilizers
33 Direct Compression
29 Parenteral
28 Controlled & Modified Release
23 Topical
20 Lubricants & Glidants
19 Film Formers & Plasticizers
16 Taste Masking
15 Co-Processed Excipients
12 Chewable & Orodispersible Aids
10 Emulsifying Agents
8 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Rheology Modifiers
4 Vegetarian Capsules
2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 64 News #PharmaBuzz

1 Data Compilation #PharmaFlow
64 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 185 Regulatory FDF Prices, 2 Annual Reports

11 US Medicaid Prescriptions
185 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

74 APIs, 38 FDF Dossiers

74 APIs
38 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 6 Health Canada Patents

8 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 19 Others

3 EDQM
1 USP
19 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 1BAYER INC

02 1Pharmascience Inc.

03 1SANDOZ CANADA INCORPORATED

filter Active Ingredients Reset all filters

3 All

01 2CIPROFLOXACIN

02 1Ciprofloxacin

filter Dosage Form Reset all filters

3 All

01 1SOLUTION

02 1SUSPENSION

03 1TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

3 All

01 1CIPRO ORAL SUSPENSION

02 1CIPROFLOXACIN INTRAVENOUS INFUSION BP

03 1PMS-CIPROFLOXACIN XL

List of Suppliers

Product Main Page

01

BAYER INC

PEGS Boston Summit

Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

CIPROFLOXACIN

Brand Name : CIPRO ORAL SUSPENSION

Dosage Form : SUSPENSION

Dosage Strength : 500MG/5ML

Packaging : 100ML

Approval Date :

Application Number : 2237514

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pharmascience Inc.

PEGS Boston Summit

Not Confirmed

Pharmascience Inc.

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Ciprofloxacin

Brand Name : PMS-CIPROFLOXACIN XL

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 500MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SANDOZ CANADA INCORPORATED

PEGS Boston Summit

Not Confirmed

SANDOZ CANADA INCORPORATED

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

CIPROFLOXACIN

Brand Name : CIPROFLOXACIN INTRAVENOUS INFUSION BP

Dosage Form : SOLUTION

Dosage Strength : 2MG/ML

Packaging : 10X100ML/10X200ML

Approval Date :

Application Number : 2304759

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.